Table 3.

Type Specificity in Genotypic Association of rs869736 with Gastric Cancer Susceptibility.

Genotype	Control (n = 406)	Diffuse-type Gastric Cancer Patient			Intestinal-type Gastric Cancer Patient
		(n = 252)	OR (95% CI)*	P	(n = 178)	OR (95% CI)*	P
GG	198 (48.8%)	96 (38.1%)	1		76 (42.7%)	1
GT	181 (44.6%)	125 (49.6%)	1.45 (1.04–2.03)	.031	84 (47.2%)	1.03 (0.68–1.56)	.87
TT	27 (6.7%)	31 (12.3%)	2.47 (1.39–4.40)	.0021	18 (10.1%)	1.52 (0.72–3.20)	.30

^*Age- and sex-adjusted OR and 95% CI in multivariate logistic regression.